Clinical Trials
42 trialsEvaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
National Institutes of Health Clinical Center (CC)
OMIM
Azienda USL Reggio Emilia - IRCCS
BASECAMP-1
A2 Biotherapeutics Inc.
COMETH
University of Kansas Medical Center
From Presentation to Diagnosis: Patterns of Pleural Effusion
Mansoura University Hospital
MESO-IMMUNE
Groupe Francais De Pneumo-Cancerologie
Imaging-Meso
Istituto Oncologico Veneto IRCCS
TIGER Meso
NovoCure Ltd.
SPECTAlung
European Organisation for Research and Treatment of Cancer - EORTC
A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma
ProgenaBiome
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
University College, London
MAGNETS
Fondazione IRCCS Policlinico San Matteo di Pavia
A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)
Bristol-Myers Squibb
Alvopem® (Pemetrexed) Safety Assessment
NanoAlvand
MESORTIBO
Centro di Riferimento Oncologico - Aviano
SCITH-MESO
Hospices Civils de Lyon
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma
Tianjin Medical University Second Hospital
PROSPECT
University of Oxford
MED-VOC
Henry Ford Health System
Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients
Istituto Clinico Humanitas
Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients
Istituto Clinico Humanitas
MESOIMMUNE
Centre Hospitalier Intercommunal Creteil
Real World Study of MPM in China
ChineseAMS
11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)
Istituto Clinico Humanitas
Clinical and Histopathologic Characteristics of BAP1 Mutations
Memorial Sloan Kettering Cancer Center
PIPACRegis
University of Magdeburg
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107
Alliance for Clinical Trials in Oncology
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
IP3R Modulation by Cancer Genes in Mesothelioma
KU Leuven
Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma
Ain Shams University
Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma
Ain Shams University
Confocal Laser Endomicroscopy in Pleural Malignancies
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collecting Tumor Samples From Patients With Gynecological Tumors
GOG Foundation
VITMPM
Ain Shams University
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
Case Comprehensive Cancer Center
Response Evaluation in Malignant Pleural Mesothelioma
Istituto Clinico Humanitas
Isolated Thoracic Perfusion (ITP-F) for MPM
Medias Klinikum for Surgical Oncology
Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients
Istituto Clinico Humanitas
Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite
Barbara Ann Karmanos Cancer Institute
Trimodality Therapy for Malignant Pleural Mesothelioma
HSK Wiesbaden
Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia
National Cancer Institute (NCI)